JAMES GILLIGAN: Open Payments
NPI 1578871026 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 24 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $344 |
| Viatris Specialty LLC | 4 | $92 |
| Electromed, Inc. | 7 | $58 |
| GENZYME CORPORATION | 2 | $40 |
| Teleflex LLC | 1 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Verona Pharma, Inc. | 1 | $33 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
Products named: BREZTRI, AIRSUPRA, YUPELRI, DUPIXENT, SMARTVEST, ARROW, Ohtuvayre, OPSUMIT.
Industry payments across AZ — which companies pay providers there.
